Zahra Dargaei

Zahra Dargaei

Auto-generated profile, based on publicly available information

Zahra Dargaei

Department of Cell and Systems Biology, University of Toronto, 25 Harbord Street, Toronto, Ontario, M5S 3G5, Canada

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2016 in Molecular Cell
Verified
Journal Article
Closed access
MQMathieu Quesnel-Vallières
Mathieu Quesnel-Vallières
ZDZahra Dargaei
Zahra Dargaei
MIManuel Irimia
Manuel Irimia
TGThomas Gonatopoulos-Pournatzis
Thomas Gonatopoulos-Pournatzis
JIJoanna Y. Ip
Joanna Y. Ip
SCSabine P. Cordes
Sabine P. Cordes

30 January 2018 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
ZDZahra Dargaei
Zahra Dargaei
JBJee Yoon Bang
Jee Yoon Bang
VMVivek Mahadevan
Vivek Mahadevan
CKC. Sahara Khademullah
C. Sahara Khademullah
SBSimon Bedard
Simon Bedard
MWMelanie A. Woodin
Melanie A. Woodin
Huntington’s disease (HD) is classically characterized as a movement disorder, however cognitive impairments precede the motor symptoms by ∼15 y. Based on proteomic and bioinformatic data linking the Huntingtin protein (Htt) and KCC2, which is required for hyperpolarizing GABAergic inhibition, and the important role of inhibition in learning and memory, we hypothesized that aberrant KCC2 function contributes to the hippocampal-associated learning and memory deficits in HD. We discovered that Htt and KCC2 interact in the hippocampi of wild-type and R6/2-HD mice, with a decrease in KCC2 expression in the hippocampus of R6/2 and YAC128 mice. The reduced expression of the Cl−-extruding cotransporter KCC2 is accompanied by an increase in the Cl−-importing cotransporter NKCC1, which together result in excitatory GABA in the hippocampi of HD mice. NKCC1 inhibition by the FDA-approved NKCC1 inhibitor bumetanide abolished the excitatory action of GABA and rescued the performance of R6/2 mice on hippocampal-associated behavioral tests. Significance Huntington’s disease (HD) is a fatal neurodegenerative disorder that currently has no cure. Although HD is classically considered a motor disorder, HD patients experience learning and memory deficits years before the onset of motor symptoms, and these deficits resemble those observed in HD mouse models. In this work, using transgenic mouse models of HD, we demonstrate that the action of the neurotransmitter GABA has switched from inhibitory to excitatory. By treating HD mice with a clinically used diuretic (bumetanide), which restores inhibitory GABA, we rescued the learning and memory deficits. Our data suggest a potential therapeutic approach for the treatment of the cognitive deficits in early HD that can improve patient quality of life and reduce caregiver burden.

13 October 2017 in eLife
Verified
Journal Article
Open access
VMVivek Mahadevan
Vivek Mahadevan
CKC Sahara Khademullah
C Sahara Khademullah
ZDZahra Dargaei
Zahra Dargaei
JCJonah Chevrier
Jonah Chevrier
PUPavel Uvarov
Pavel Uvarov
MWMelanie A Woodin
Melanie A Woodin
KCC2 is a neuron-specific K+-Cl– cotransporter essential for establishing the Cl- gradient required for hyperpolarizing inhibition in the central nervous system (CNS). KCC2 is highly localized to excitatory synapses where it regulates spine morphogenesis and AMPA receptor confinement. Aberrant KCC2 function contributes to human neurological disorders including epilepsy and neuropathic pain. Using functional proteomics, we identified the KCC2-interactome in the mouse brain to determine KCC2-protein interactions that regulate KCC2 function. Our analysis revealed that KCC2 interacts with diverse proteins, and its most predominant interactors play important roles in postsynaptic receptor recycling. The most abundant KCC2 interactor is a neuronal endocytic regulatory protein termed PACSIN1 (SYNDAPIN1). We verified the PACSIN1-KCC2 interaction biochemically and demonstrated that shRNA knockdown of PACSIN1 in hippocampal neurons increases KCC2 expression and hyperpolarizes the reversal potential for Cl-. Overall, our global native-KCC2 interactome and subsequent characterization revealed PACSIN1 as a novel and potent negative regulator of KCC2.

22 December 2016 in Nature Communications
Verified
Journal Article
Open access
AAAfif J. Aqrabawi
Afif J. Aqrabawi
CBCaleb J. Browne
Caleb J. Browne
ZDZahra Dargaei
Zahra Dargaei
DGDanielle Garand
Danielle Garand
CKC. Sahara Khademullah
C. Sahara Khademullah
JKJun Chul Kim
Jun Chul Kim
Olfactory processing is thought to be actively modulated by the top-down input from cortical regions, but the behavioural function of these signals remains unclear. Here we find that cortical feedback from the anterior olfactory nucleus pars medialis (mAON) bidirectionally modulates olfactory sensitivity and olfaction-dependent behaviours. To identify a limbic input that tunes this mAON switch, we further demonstrate that optogenetic stimulation of ventral hippocampal inputs to the mAON is sufficient to alter olfaction-dependent behaviours.

1 March 2020 in Brain
Verified
Journal Article
Closed access
CKC Sahara Khademullah
C Sahara Khademullah
AAAfif J Aqrabawi
Afif J Aqrabawi
KPKara M Place
Kara M Place
ZDZahra Dargaei
Zahra Dargaei
XLXinyi Liang
Xinyi Liang
MWMelanie A Woodin
Melanie A Woodin
Amyotrophic lateral sclerosis is a fatal disease resulting from motor neuron degeneration in the cortex and spinal cord. Cortical hyperexcitability is a hallmark feature of amyotrophic lateral sclerosis and is accompanied by decreased intracortical inhibition. Using electrophysiological patch-clamp recordings, we revealed parvalbumin interneurons to be hypoactive in the late pre-symptomatic SOD1*G93A mouse model of amyotrophic lateral sclerosis. We discovered that using adeno-associated virus-mediated delivery of chemogenetic technology targeted to increase the activity of the interneurons within layer 5 of the primary motor cortex, we were able to rescue intracortical inhibition and reduce pyramidal neuron hyperexcitability. Increasing the activity of interneurons in the layer 5 of the primary motor cortex was effective in delaying the onset of amyotrophic lateral sclerosis-associated motor deficits, slowing symptom progression, preserving neuronal populations, and increasing the lifespan of SOD1*G93A mice. Taken together, this study provides novel insights into the pathogenesis and treatment of amyotrophic lateral sclerosis.

1 April 2017 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
JPJessica C. Pressey
Jessica C. Pressey
VMVivek Mahadevan
Vivek Mahadevan
CKC. Sahara Khademullah
C. Sahara Khademullah
ZDZahra Dargaei
Zahra Dargaei
JCJonah Chevrier
Jonah Chevrier
MWMelanie A. Woodin
Melanie A. Woodin
Synaptic inhibition depends on a transmembrane gradient of chloride, which is set by the neuron-specific K+-Cl− co-transporter KCC2. Reduced KCC2 levels in the neuronal membrane contribute to the generation of epilepsy, neuropathic pain, and autism spectrum disorders; thus, it is important to characterize the mechanisms regulating KCC2 expression. In the present study, we determined the role of KCC2-protein interactions in regulating total and surface membrane KCC2 expression. Using quantitative immunofluorescence in cultured mouse hippocampal neurons, we discovered that the kainate receptor subunit GluK2 and the auxiliary subunit Neto2 significantly increase the total KCC2 abundance in neurons but that GluK2 exclusively increases the abundance of KCC2 in the surface membrane. Using a live cell imaging assay, we further determined that KCC2 recycling primarily occurs within 1–2 h and that GluK2 produces an ∼40% increase in the amount of KCC2 recycled to the membrane during this time period. This GluK2-mediated increase in surface recycling translated to a significant increase in KCC2 expression in the surface membrane. Moreover, we found that KCC2 recycling is enhanced by protein kinase C-mediated phosphorylation of the GluK2 C-terminal residues Ser-846 and Ser-868. Lastly, using gramicidin-perforated patch clamp recordings, we found that the GluK2-mediated increase in KCC2 recycling to the surface membrane translates to a hyperpolarization of the reversal potential for GABA (EGABA). In conclusion, our results have revealed a mechanism by which kainate receptors regulate KCC2 expression in the hippocampus.